WeTrials
Recruiting

Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis

What is this study?

This study tests a new way to treat an aggressive type of brain tumor called glioblastoma using chemotherapy alongside a special gene therapy. The goal is to protect your bone marrow so doctors can use higher, more effective doses of cancer-fighting medicine.

Who can participate?

You may be able to join if you are 18 or older, had recent surgery to remove a specific type of upper brain tumor within the last 35 days, and are generally well enough to handle daily activities. Certain health conditions, pregnancy, or major heart and lung issues will mean you cannot participate.

What will happen?

You will receive treatments including chemotherapy medications, radiation therapy, and a special bone marrow protection therapy to help your body handle the strong medicines. Doctors will monitor you closely with scans and checkups throughout the process.

Where and when?

This study is currently recruiting participants and takes place in Cleveland, Ohio, United States.

Key Points
  • 1Tests stronger chemotherapy doses while protecting your bone marrow
  • 2For adults with a specific type of recently removed brain tumor
  • 3Currently recruiting patients in Cleveland, Ohio

Related video

Fred Hutch: earlier stem-cell gene therapy research in glioblastoma (2016)

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Glioblastoma MultiformeGlioblastoma Multiforme, AdultSupratentorial GlioblastomaSupratentorial Gliosarcoma

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.